NCT04819633View on ClinicalTrials.gov

Evaluating Serum Sestrin in Leiomyoma Patients

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

March 1, 2021

Study Completion Date

April 1, 2021

Conditions
Uterine Leiomyoma
Interventions
OTHER

Determination of serum sestrin levels

Serum sestrin levels will be determined using venous blood samples obtained from the subjects.

Trial Locations (1)

34371

Sisli Hamidiye Etfal Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Sisli Hamidiye Etfal Training and Research Hospital

OTHER

NCT04819633 - Evaluating Serum Sestrin in Leiomyoma Patients | Biotech Hunter | Biotech Hunter